ADC Therapeutics raises $105M in common share and warrant offering, with closing on May 8; led by Jefferies, Guggenheim Securities, and Cantor.
ADC Therapeutics SA announced a $105M underwritten offering of common shares at $4.90 per share and pre-funded warrants to purchase shares at $4.812 per warrant. The gross proceeds before discount and expenses are expected to be $105M, with closing on May 8, subject to conditions. Jefferies, Guggenheim Securities, and Cantor serve as joint book-running managers.
May 06, 2024
3 Articles